Robert Stevenson
Stock Analyst at Janney Montgomery
(4.02)
# 1,751
Out of 4,966 analysts
108
Total ratings
67.1%
Success rate
10.1%
Average return
Main Sectors:
Stocks Rated by Robert Stevenson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SBRA Sabra Health Care REIT | Initiated: Buy | $23 | $20.83 | +10.42% | 1 | Sep 11, 2026 | |
| NHI National Health Investors | Initiated: Buy | $79 | $70.21 | +12.52% | 1 | Sep 11, 2026 | |
| JAN Janus Living | Initiated: Buy | $36 | $30.81 | +16.85% | 1 | Sep 11, 2026 | |
| HIW Highwoods Properties | Reiterated: Buy | n/a | $30.28 | - | 8 | Jan 13, 2026 | |
| GTY Getty Realty | Initiated Coverage: Buy | $30 | $32.76 | -8.42% | 1 | Oct 16, 2025 | |
| CHCT Community Healthcare Trust | Reiterated: Buy | n/a | $14.49 | n/a | 4 | Apr 30, 2025 | |
| ESS Essex Property Trust | Reiterated: Hold | n/a | $274.37 | n/a | 5 | Apr 30, 2025 | |
| VMRK Vivmark Residential | Reiterated: Hold | n/a | $64.98 | n/a | 6 | Apr 30, 2025 | |
| CSR Centerspace | Upgraded: Buy | $72 | $57.36 | n/a | 5 | Jan 15, 2025 | |
| DEI Douglas Emmett | Downgraded: Hold | $19 | $10.78 | n/a | 2 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $43 | $44.13 | n/a | 7 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $13.91 | n/a | 1 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $6.42 | n/a | 3 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $59.67 | n/a | 4 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 → $18 | $12.86 | n/a | 5 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $72.59 | n/a | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $60.97 | n/a | 4 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.66 | n/a | 1 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $18.93 | n/a | 2 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $150 | $127.48 | n/a | 4 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.3838 | n/a | 2 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $16 | $23.63 | n/a | 3 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $104.11 | n/a | 4 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $36 | $22.86 | n/a | 2 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $35.40 | n/a | 2 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $60 | $60.11 | n/a | 4 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $14 → $16 | $10.75 | n/a | 4 | Jan 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 → $25 | $21.40 | n/a | 3 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $30 | $24.52 | n/a | 2 | Aug 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $30 | $9.46 | n/a | 2 | Dec 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $36.98 | n/a | 5 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $14.16 | n/a | 1 | Sep 29, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 → $41 | $2.46 | n/a | 2 | Sep 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $57 | $81.07 | n/a | 1 | Apr 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $135.05 | n/a | 1 | Mar 4, 2009 |
Sabra Health Care REIT
Sep 11, 2026
Initiated: Buy
Price Target: $23
Current: $20.83
Upside: +10.42%
National Health Investors
Sep 11, 2026
Initiated: Buy
Price Target: $79
Current: $70.21
Upside: +12.52%
Janus Living
Sep 11, 2026
Initiated: Buy
Price Target: $36
Current: $30.81
Upside: +16.85%
Highwoods Properties
Jan 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $30.28
Upside: -
Getty Realty
Oct 16, 2025
Initiated Coverage: Buy
Price Target: $30
Current: $32.76
Upside: -8.42%
Community Healthcare Trust
Apr 30, 2025
Reiterated: Buy
Price Target: n/a
Current: $14.49
Upside: n/a
Essex Property Trust
Apr 30, 2025
Reiterated: Hold
Price Target: n/a
Current: $274.37
Upside: n/a
Vivmark Residential
Apr 30, 2025
Reiterated: Hold
Price Target: n/a
Current: $64.98
Upside: n/a
Centerspace
Jan 15, 2025
Upgraded: Buy
Price Target: $72
Current: $57.36
Upside: n/a
Douglas Emmett
Jan 15, 2025
Downgraded: Hold
Price Target: $19
Current: $10.78
Upside: n/a
Jan 15, 2025
Downgraded: Hold
Price Target: $43
Current: $44.13
Upside: n/a
Dec 18, 2024
Initiated Coverage: Buy
Price Target: $13
Current: $13.91
Upside: n/a
Nov 21, 2024
Reiterated: Buy
Price Target: n/a
Current: $6.42
Upside: n/a
Nov 21, 2024
Reiterated: Buy
Price Target: n/a
Current: $59.67
Upside: n/a
Nov 21, 2024
Reiterated: Hold
Price Target: $18 → $18
Current: $12.86
Upside: n/a
Nov 12, 2024
Reiterated: Buy
Price Target: n/a
Current: $72.59
Upside: n/a
Nov 12, 2024
Reiterated: Buy
Price Target: n/a
Current: $60.97
Upside: n/a
Nov 12, 2024
Reiterated: Buy
Price Target: n/a
Current: $15.66
Upside: n/a
Jul 19, 2024
Reiterated: Buy
Price Target: n/a
Current: $18.93
Upside: n/a
Jun 13, 2024
Upgraded: Buy
Price Target: $150
Current: $127.48
Upside: n/a
Feb 27, 2024
Reiterated: Hold
Price Target: n/a
Current: $0.3838
Upside: n/a
Feb 27, 2024
Reiterated: Buy
Price Target: $18 → $16
Current: $23.63
Upside: n/a
Dec 20, 2023
Reiterated: Buy
Price Target: n/a
Current: $104.11
Upside: n/a
Dec 20, 2023
Downgraded: Hold
Price Target: $36
Current: $22.86
Upside: n/a
Dec 20, 2023
Reiterated: Hold
Price Target: n/a
Current: $35.40
Upside: n/a
Oct 16, 2023
Reiterated: Hold
Price Target: $60
Current: $60.11
Upside: n/a
Jan 13, 2023
Upgraded: Buy
Price Target: $14 → $16
Current: $10.75
Upside: n/a
Sep 16, 2022
Reiterated: Buy
Price Target: $55 → $25
Current: $21.40
Upside: n/a
Aug 1, 2022
Downgraded: Hold
Price Target: $32 → $30
Current: $24.52
Upside: n/a
Dec 6, 2021
Reiterated: Buy
Price Target: $11 → $30
Current: $9.46
Upside: n/a
Jul 10, 2020
Reiterated: Buy
Price Target: n/a
Current: $36.98
Upside: n/a
Sep 29, 2017
Rated: Hold
Price Target: n/a
Current: $14.16
Upside: n/a
Sep 9, 2015
Upgraded: Buy
Price Target: $40 → $41
Current: $2.46
Upside: n/a
Apr 9, 2015
Initiated Coverage: Hold
Price Target: $57
Current: $81.07
Upside: n/a
Mar 4, 2009
Reiterated: Buy
Price Target: n/a
Current: $135.05
Upside: n/a